Science Diplomats Tackling Our Lifestyle Killers
Organised by Dr. Michel Kazatchkine, UN Secretary General’s Ban-Ki Moon’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia; Former Executive Director of the Global Fund to Fight Aids, Tuberculosis & Malaria. Co-organised by: Aidan Gilligan, Founder, CEO SciCom - Making Sense of Science; Member of the Governing Board of Euroscience.
Global perspectives and issues - AAAS 2015
Saturday, 14 February 2015: 3:00 PM-4:30 PM
Room 210G (San Jose Convention Center)
https://aaas.confex.com/aaas/2015/webprogram/Session9569.html
Session Description
Science-based issues are crucial to the conduct of foreign policy. Countries large and small, developed and developing, express a clear interest in implementing science diplomacy through politics. This is for the purpose of representation, cooperation, resolving disputes, improving systems, and securing the right to science for citizens and our most vulnerable populations. The same applies to global companies and institutions operating in a complex matrix of technical and relational challenges. This symposium will test this theory against the successes and failures of health diplomacy strategies around two challenging issues: global responses to obesity and harm reduction science linked to lifestyle.
E-Cigarettes Evidence & Ethics - AAAS 2015
E-cigarettes: Killing Me Softly or Our Greatest Public Health Opportunity?
Organised by Professor Julian Kinderlerer, President of the European Group on Ethics in Science and New Technologies (EGE), reporting to European Commission President, José Manuel Barroso; Emeritus Professor of Intellectual Property Law, University of Cape Town; Adviser to the South African Dept. of S&T; Occasional Adviser to the UN Environment Programme, UN Industrial Development Organisation & World Intellectual Property Organisation. Co-organised by: Aidan Gilligan, Founder, CEO SciCom - Making Sense of Science; Member of the Governing Board of Euroscience.
E-Cigarettes Evidence & Ethics - AAAS 2015
Friday, 13 February 2015: 1:00 PM-2:30 PM
Room 230B (San Jose Convention Center)
https://aaas.confex.com/aaas/2015/webprogram/Session9274.html
Session Description
1.3 billion people smoke and this will kill half of them. Not since the Internet has society seen a comparative disruptive technology with the capacity to so fundamentally impact lives as the electronic cigarette. Hundreds of versions have sprung up, specialised shops cannot be built fast enough and Wells Fargo (2013) predicts that sales will outstrip classical cigarettes by 2021. 80% of smokers want to quit, over 50% have tried e-cigs of which 33% continue to use them, but 33% of these actually give up nicotine altogether (ASH UK).
Building Global Partnerships: Sharing Discovery While Protecting Competition
Organised by: Ms Grace Naledi Mandisa Pandor, South African Minister for Science and Technology Co-organised by: Aidan Gilligan, Founder, CEO SciCom - Making Sense of Science; Member of the Governing Board of Euroscience.
Science Policy - European Science Open Forum (ESOF), Copenhagen
15h00 – 17h45, Wednesday 25 June 2014 (Pompeii Hall, Carlsberg Academy)
Session Description
A global village, an interconnected world, a harmonious scientific community: these are some of the well-quoted end points of science diplomacy. As we strive to understand and mitigate challenges: in climate change, energy and resource efficiency, health and demographic change, food security and the digital divide, global partnerships must be built and sustained. This is not easy. Neither is a one-size-fits-all approach always the best option.
E-cigarettes: Killing Me Softly or Our Greatest Public Health Opportunity?
Organised by Aidan Gilligan, Founder, CEO SciCom - Making Sense of Science; Member of the Governing Board of Euroscience.
E-Cigarettes Evidence & Ethics - ESOF 2014
10:30 - 11:45 , June 25 2014 (Malting Hall)
Session Description
Not since the Internet has society seen a comparative disruptive technology with the capacity to so fundamentally impact lives as the electronic cigarette. Hundreds of versions have sprung up, online sales are sky-rocketing and specialized e-cig shops cannot be built fast enough. Tens of millions of smokers have made the switch in a tidal-wave of support. Yet, are e-cigs ‘safe’ or simply ‘safer’ than classical cigarettes. If the former, shouldn’t all harm reduction advocates welcome them? Or does their nicotine-infused vapor risk developing cancer in certain types of human cells much in the same way that tobacco smoke does? Are they child-proof enough?
